56 related articles for article (PubMed ID: 22486560)
1. Cure of a thyrotrophin (TSH)-secreting pituitary adenoma by medical therapy.
Fliers E; van Furth WR; Bisschop PH
Clin Endocrinol (Oxf); 2012 Nov; 77(5):788-90. PubMed ID: 22486560
[No Abstract] [Full Text] [Related]
2. Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature.
Yoenem A; Cakyr B; Azal O; Corakcy A; Kutlu M; Oezata M
Endocr Regul; 1999 Dec; 33(4):169-74. PubMed ID: 10700085
[TBL] [Abstract][Full Text] [Related]
3. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
4. [Octreotide in the diagnosis and treatment of pituitary thyrotropin-secreting adenoma].
Chen S; Li M; Lian XL; Zeng ZP; Dai WX; Li F; Yu W; Wang RZ
Zhonghua Nei Ke Za Zhi; 2006 Nov; 45(11):910-3. PubMed ID: 17313878
[TBL] [Abstract][Full Text] [Related]
5. [Response of thyrotropinoma to somatostatin analogues: report of a case].
García Lafuente N; Berná Gascón MT; Pujalte López E; Falcó Jover G; Domínguez Escribano JR
An Med Interna; 2001 Dec; 18(12):663. PubMed ID: 11852512
[No Abstract] [Full Text] [Related]
6. Thyrotropin secreting pituitary adenoma effectively treated with octreotide.
Fukuda T; Yokoyama N; Tamai M; Imaizumi M; Kimura H; Tominaga T; Ashizawa K; Kiriyama T; Yoshimine H; Ohishi K; Eguchi K
Intern Med; 1998 Dec; 37(12):1027-30. PubMed ID: 9932634
[TBL] [Abstract][Full Text] [Related]
7. Use of somatostatin analogue in management of a thyrotrophin secreting pituitary adenoma.
Stiles MK; Conaglen JV; Speed J; Chatterton B
Aust N Z J Med; 1996 Feb; 26(1):122-3. PubMed ID: 8775545
[No Abstract] [Full Text] [Related]
8. The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy.
Blackhurst G; Strachan MW; Collie D; Gregor A; Statham PF; Seckl JE
Clin Endocrinol (Oxf); 2002 Sep; 57(3):401-4. PubMed ID: 12201834
[TBL] [Abstract][Full Text] [Related]
9. [Thyroid-stimulating hormone hypophyseal adenoma. A case report].
Gannage MH; Maacaron C; Okais N; Halaby G
J Med Liban; 1997; 45(2):97-101. PubMed ID: 9289506
[TBL] [Abstract][Full Text] [Related]
10. TSH secreting pituitary adenoma: a rare cause of thyrotoxicosis.
So WY; Yeung VT; Chow CC; Ko GT; Szeto CC; Cockram CS
Int J Clin Pract; 1998; 52(1):62-4. PubMed ID: 9536575
[TBL] [Abstract][Full Text] [Related]
11. [Octreotide in the treatment of thyrotropin-secreting pituitary adenomas].
Podoba J; Hnilica P; Makaiová I; Kovácová S; Rybár M; Gecík K; Belan V; Steno J
Vnitr Lek; 1997 Sep; 43(9):607-10. PubMed ID: 9750471
[TBL] [Abstract][Full Text] [Related]
12. [Monosymptomatic hyperthyroidism and TSH-producing adenoma: successful therapy with octreotide].
Mayinger B; Axelos D; Pavel M; Hahn EG; Hensen J
Dtsch Med Wochenschr; 1999 Jan; 124(4):73-8. PubMed ID: 10071603
[TBL] [Abstract][Full Text] [Related]
13. TSH producing pituitary tumor: biochemical diagnosis and long-term medical management with octreotide.
Chayen SD; Gross D; Makhoul O; Glaser B
Horm Metab Res; 1992 Jan; 24(1):34-8. PubMed ID: 1612557
[TBL] [Abstract][Full Text] [Related]
14. Primary treatment of a combined somatotropin- and thyrotropin-secreting pituitary tumour with octreotide.
Walsh JP; Glatthaar C; Pullan PT
Aust N Z J Med; 1996 Feb; 26(1):124-5. PubMed ID: 8775546
[No Abstract] [Full Text] [Related]
15. [TSH-secreting pituitary adenoma: 16 years follow-up].
Koch CA; Skarulis MC; Patronas NJ; Sarlis NJ
Med Klin (Munich); 2000 Jan; 95(1):49-50. PubMed ID: 10668345
[No Abstract] [Full Text] [Related]
16. Thyrotropin secreting pituitary adenoma accompanying a silent somatotropinoma.
Berker D; Isik S; Aydin Y; Tutuncu Y; Akdemir G; Ozcan HN; Guler S
Turk Neurosurg; 2011; 21(3):403-7. PubMed ID: 21845579
[TBL] [Abstract][Full Text] [Related]
17. Different responses to chronic somatostatin analogues in patients with central hyperthyroidism.
Mannavola D; Persani L; Vannucchi G; Zanardelli M; Fugazzola L; Verga U; Facchetti M; Beck-Peccoz P
Clin Endocrinol (Oxf); 2005 Feb; 62(2):176-81. PubMed ID: 15670193
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the long-acting octreotide formulation in patients with thyroid-stimulating hormone-secreting pituitary adenomas after incomplete surgery and octreotide treatment failure.
Zhang CF; Liang D; Zhong LY
Chin Med J (Engl); 2012 Aug; 125(15):2758-63. PubMed ID: 22931988
[TBL] [Abstract][Full Text] [Related]
19. [Hypophyseal thyrotropin adenomas at Yaounde (Cameroon). Analysis of two case reports: improvement with somatostatin analogue (SMS 201-995)].
Nouedoui C; Moukouri E; Juimo AG; Dongmo L; Zok FD; Tapko JB; Muna WF
Tunis Med; 1999 Mar; 77(3):154-8. PubMed ID: 10392035
[No Abstract] [Full Text] [Related]
20. Thyrotrophin (TSH)-secreting pituitary macroadenoma with cavernous sinus invasion.
Kon YC; Loh KC; Tambyah JA; Lim LH; Marshall JC
Singapore Med J; 2001 Sep; 42(9):433-7. PubMed ID: 11811613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
